Daily non-political popular news in brief.

Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients

Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents. Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body. In a paper presented at the NSTI Nanotech 2007 Conference, researchers at the University of California, San Francisco demonstrate how they have created nanotubes from biocompatible metal oxides that can hold therapeutic proteins or drugs and deliver these agents in a highly-controlled manner.

Read more »

Keywords: drug, eluting, nanostructured, coatings, enable, targeted, therapy, orthopedic, patients, coating, patient

« Previous | Next »

Similar news on "Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients":

1. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
2. Gene patenting -- steep cost for health care and patients
   05-07-2007 · EurekAlert!
   The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
   Similar news · Read more »
   
3. New drug helps hepatitis C patients start antiviral therapy
   10-30-2006 · EurekAlert!
   A new drug that stimulates the production of blood platelets can enable patients infected with hepatitis C virus to take other antiviral medications they previously could not take to fight the disease, according to the results of a clinical trial led by a Duke University Medical Center researcher.
   Similar news · Read more »
   
4. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
5. Drug combination shrinks breast cancer metastases in brain
   12-16-2007 · EurekAlert!
   A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber Cancer Institute investigators at the San Antonio Breast Cancer Symposium.
   Similar news · Read more »
   
6. Early Phase II results show bosutinib safe, effective for CML
   12-11-2007 · EurekAlert!
   A new drug for chronic myelogenous leukemia works for patients who have developed resistance to frontline therapy and causes fewer side effects than other medications in its class, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports at the 49th annual meeting of the American Society of Hematology.
   Similar news · Read more »
   
7. Rehabilitation technique for stroke patients effective in improving arm, hand movement
   10-31-2006 · EurekAlert!
   Therapy that includes restraining the less-impaired arm or hand of a stroke patient appears effective in improving movement and functional use of the paralyzed arm or hand, according to a study in the Nov. 1 issue of JAMA.
   Similar news · Read more »
   
8. UF researchers test stem cell therapy for heart patients
   10-04-2007 · EurekAlert!
   University of Florida doctors treated the first patient in a new study to test whether a person's own stem cells can be used to restore blood flow to the heart by prompting new blood vessels to grow.
   Similar news · Read more »
   
9. New mechanism identified for resistance to targeted lung cancer drugs
   04-26-2007 · EurekAlert!
   An international research team, led by investigators from the Massachusetts General Hospital Cancer Center and Dana-Farber Cancer Institute, has found a new way that some lung tumors become resistant to treatment with targeted therapy drugs like Iressa and Tarceva. Their report describes a totally new resistance mechanism that may apply to many types of cancer and suggests a treatment strategy for patients with these resistant tumors.
   Similar news · Read more »
   
10. Late angioplasty after heart attack no better than drug therapy
    11-14-2006 · EurekAlert!
    About one-third of heart attack patients do not receive treatment to open blocked arteries within the recommended 12-hours after a heart attack. For years it has been thought that late balloon angioplasty of these patients' arteries, if they are totally blocked, is still beneficial. However, a large clinical trial found that stable patients who had angioplasty plus stenting three to 28 days after a heart attack did no better than patients on drug treatment alone.
    Similar news · Read more »